Choosing a Gliptin
The treatment of type 2 diabetes mellitus (T2DM) has included the use of metformin and sulfonylurea (SU) as first-line anti-diabetic therapies world over since years. This remains, despite the knowledge that the combination results in a progressive decline in [beta]-cell function and by 3 years up t...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Wolters Kluwer Medknow Publications
2011-01-01
|
| シリーズ: | Indian Journal of Endocrinology and Metabolism |
| 主題: | |
| オンライン･アクセス: | http://www.ijem.in/article.asp?issn=2230-8210;year=2011;volume=15;issue=4;spage=298;epage=308;aulast=Gupta |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|